Status:
COMPLETED
Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
12-70 years
Brief Summary
Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.
Eligibility Criteria
Inclusion
- Patients with Relapsing Remitting Multiple Sclerosis (RRMS), and treated with Betaferon, with the decision for treatment made at the discretion of the attending physician, documented with a prescription of Betaferon by the physician
- EDSS 0 - 6
- Written informed consent
Exclusion
- Patients who do not meet the local indication criteria for Betaferon treatment.
- Contraindications listed in the local SmPCs have to be considered.
- Patients with a history of severe head trauma.
- Patients with alcohol and/or drug abuse.
- Patients with mental retardation.
- Patients with learning disability.
Key Trial Info
Start Date :
April 30 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2017
Estimated Enrollment :
1085 Patients enrolled
Trial Details
Trial ID
NCT01491100
Start Date
April 30 2012
End Date
April 5 2017
Last Update
April 5 2018
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Albania
2
Multiple Locations, Algeria
3
Multiple Locations, Argentina
4
Multiple Locations, Belgium